← Back to Clinical Trials
Recruiting NCT06169592

NCT06169592 Verification of Risk Factors of Thrombohemorrhagic Complications in Recipients After Related Liver Transplantation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06169592
Status Recruiting
Phase
Sponsor Republican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov
Condition Liver Cirrhosis
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2022-04-22
Primary Completion 2026-11-14

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 70 Years
Study Type OBSERVATIONAL
Interventions
Liver transplantation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30 participants in total. It began in 2022-04-22 with a primary completion date of 2026-11-14.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of the study is to improve the results of related transplantation of the right liver lobe by verifying the general predictors of the development of hemostatic system disorders and optimizing a comprehensive program for thrombohemorrhagic complications preventing.

Eligibility Criteria

Inclusion Criteria: * Age over 18 years and up to 70 years; * Signed informed consent for inclusion to the study; * End stage liver cirrhosis. Exclusion Criteria: * Pregnancy; * Extrahepatic factors influencing systemic hemostasis; * Concomitant hematological diseases affecting the hemostatic system; * Severe concomitant disorders.

Contact & Investigator

Central Contact

Azam Babadjanov, Professor

✉ azambabadjanov@gmail.com

📞 +998901751703

Frequently Asked Questions

Who can join the NCT06169592 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Liver Cirrhosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06169592 currently recruiting?

Yes, NCT06169592 is actively recruiting participants. Contact the research team at azambabadjanov@gmail.com for enrollment information.

Where is the NCT06169592 trial being conducted?

This trial is being conducted at Tashkent, Uzbekistan.

Who is sponsoring the NCT06169592 clinical trial?

NCT06169592 is sponsored by Republican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology